| 1 |
33224343 | Statins and C-reactive protein: in silico evidence on direct interaction. | 2020 |
1 |
| 2 |
28302952 | Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS. | 2017 Oct 1 |
3 |
| 3 |
26747436 | Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials. | 2016 Apr |
1 |
| 4 |
26020669 | [Effect of pravastatine plus ezetimibe on carotid intima media thickness in patients with lupus erythematosus]. | 2015 |
1 |
| 5 |
24211751 | Anti-inflammatory interventions in end-stage kidney disease: a randomized, double-blinded, controlled and crossover clinical trial on the use of pravastatin in continuous ambulatory peritoneal dialysis. | 2013 Nov |
3 |
| 6 |
21422984 | High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors. | 2011 May 15 |
1 |
| 7 |
20349300 | Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation. | 2010 Mar |
3 |
| 8 |
19143751 | Effects of pravastatin on the function of dendritic cells in patients with coronary heart disease. | 2009 Feb |
1 |
| 9 |
18632424 | Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. | 2008 Jun |
2 |
| 10 |
18855257 | Comparison of the effect of lipophilic and hydrophilic statins on serum adiponectin levels in patients with mild hypertension and dyslipidemia: Kinki Adiponectin Interventional (KAI) Study. | 2008 Oct |
1 |
| 11 |
20157364 | Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin. | 2008 Jul |
3 |
| 12 |
17112529 | Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. | 2007 Oct |
1 |
| 13 |
17283264 | C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). | 2007 Feb 27 |
2 |
| 14 |
17996517 | Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol. | 2007 Nov 15 |
6 |
| 15 |
16054696 | Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist. | 2006 Mar |
3 |
| 16 |
16343471 | Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. | 2006 Apr |
1 |
| 17 |
16444450 | Time course of rapid C-reactive protein reduction by pravastatin in patients with stable angina. | 2006 Jan-Feb |
3 |
| 18 |
16714254 | Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients. | 2006 |
2 |
| 19 |
15635109 | C-reactive protein levels and outcomes after statin therapy. | 2005 Jan 6 |
2 |
| 20 |
15801991 | Effects of switching pravastatin to cerivastatin on C-reactive protein, butyrylcholinesterase, and lipids. | 2005 Feb |
2 |
| 21 |
15893181 | Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. | 2005 May 17 |
1 |
| 22 |
15954913 | Biomarkers of inflammation and progression of chronic kidney disease. | 2005 Jul |
1 |
| 23 |
16126025 | Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. | 2005 Sep 5 |
1 |
| 24 |
14996776 | Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. | 2004 Mar 3 |
1 |
| 25 |
15265816 | Early effect of pravastatin on serum soluble CD40L, matrix metalloproteinase-9, and C-reactive protein in patients with acute myocardial infarction. | 2004 Sep |
1 |
| 26 |
15469788 | [Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation]. | 2004 Oct |
5 |
| 27 |
15540478 | HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. | 2004 Aug 15 |
2 |
| 28 |
12595863 | Effect of atorvastatin and pravastatin on serum C-reactive protein. | 2003 Feb |
5 |
| 29 |
11893365 | Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. | 2002 Mar |
1 |
| 30 |
11174913 | Inflammation and coronary heart disease: an overview. | 2001 Jan-Feb |
1 |
| 31 |
11305529 | Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy. | 2001 Mar |
1 |
| 32 |
11306519 | Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. | 2001 Apr 17 |
2 |
| 33 |
11434828 | Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. | 2001 Jul 4 |
7 |
| 34 |
10411845 | Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. | 1999 Jul 20 |
6 |